Once-yearly treatment for convenience
A single yearly infusion removes the need for frequent dosing, making treatment simple and easy to maintain.
Aclasta Infusion for Osteoporosis: What You Need to Know
Strengthen your bones and reduce fracture risk with a simple, once-yearly treatment.
Osteoporosis is a common condition that weakens bones and increases the risk of fractures, particularly as we age.
At Madison Medical Practice Northbridge, we offer Aclasta (zoledronic acid) infusions as an effective treatment option to help strengthen bones and reduce fracture risk.
What is Aclasta?
A simple once-yearly treatment to help strengthen bones
Aclasta is a prescription treatment for osteoporosis, a condition that weakens bones and increases fracture risk.
It contains zoledronic acid, a medicine that helps slow bone loss and improve bone strength over time.
Aclasta is given as a once-yearly infusion in a clinic, usually taking about 15–30 minutes. It offers a simple alternative to regular osteoporosis tablets.
It is commonly used for patients who have osteoporosis, are at higher risk of fractures, or cannot tolerate oral medications.
Before treatment, your GP will assess your suitability and may arrange blood tests to ensure it is safe for you.
What to Expect During Treatment
Step 1: GP Assessment
Your GP will assess your suitability by reviewing your medical history and current medications.
Step 2: Pre-Treatment Tests
Blood tests may be arranged to check your kidney function and calcium levels before treatment.
Step 3: Infusion Appointment
The infusion is administered in-clinic and usually takes around 15–30 minutes.
Step 4: Aftercare
Most patients tolerate the treatment well. Some may experience mild flu-like symptoms after the first dose, which are temporary and manageable.
Benefits of Aclasta
Supporting bone strength and reducing fracture risk
Helps improve bone density
Works by slowing bone loss, helping to maintain and strengthen bone over time.
Reduces the risk of fractures
Stronger bones mean a lower risk of fractures, particularly in the hip and spine.
Suitable alternative to oral medications
Ideal for patients who cannot tolerate tablets or prefer not to take regular oral medication.
Side Effects & Safety
Aclasta is generally well tolerated. However, some patients may experience mild flu-like symptoms after the first infusion, including:
Fever
Muscle aches
Fatigue
These symptoms are usually short-lived and resolve within a few days. Your GP will discuss any potential risks and ensure the treatment is safe and appropriate for you.
Have any questions?
Frequently Asked Questions (FAQ)
Aclasta is a prescription medication containing zoledronic acid used to treat osteoporosis by strengthening bones and reducing fracture risk.
Aclasta is typically given once a year as a single intravenous infusion.
The infusion usually takes about 15–30 minutes and is performed in the clinic.
Aclasta may be recommended for people with osteoporosis, especially those who cannot tolerate oral medications or need long-term bone protection. Your GP will determine if it’s appropriate for you.
Some patients experience mild flu-like symptoms after the first infusion. These usually resolve within a few days. Serious side effects are rare and will be discussed beforehand.
Yes, your GP may arrange blood tests to check your kidney function and calcium levels before proceeding.
Stay well hydrated and rest if needed. Over-the-counter pain relief may help if you experience mild symptoms—your GP will advise you.